Abstract
Here we report an unusual case of RT without any clinical, laboratory, or radiologic evidence suggestive of transformation other than cytopenia. Without any significant extramedullary involvement, RT presented in a leukemic phase that mimicked acute myeloid leukemia (AML). Importantly, despite the presence of a number of risk factors associated with a poor outcome, such as clonal relatedness, complex karyotype, expression of CD38 and ZAP70, thrombocytopenia, and multiple prior therapies, the patient responded well to ibrutinib monotherapy. This article is protected by copyright. All rights reserved.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
